EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease
- PMID: 30312704
- PMCID: PMC6490677
- DOI: 10.1016/j.jaci.2018.09.019
EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease
Abstract
We demonstrate for the first time that EROS (CYBC1/C17ORF62) regulates abundance of the gp91phox-p22phox heterodimer of the phagocyte NADPH oxidase in human cells and that EROS mutations are a novel cause of chronic granulomatous disease.
Conflict of interest statement
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures


References
-
- Conti F, Lugo-Reyes SO, Blancas Galicia L, He J, Aksu G, Borges de Oliveira E Jr., et al. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases. The Journal of allergy and clinical immunology. 2016;138(1):241–8 e3. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases